bioMérieux Stock
Stocks
BIM
FR0013280286
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Euronext Paris
12:55:00 2026-10-29 EDT
|
5-day change | 1st Jan Change | ||
| 90.15 EUR | -0.93% |
|
+4.52% | -18.27% |
| 10-28 | Deutsche Bank Research Upgrades bioMérieux to Buy, Boosts PT | MT |
| 10-22 | BioMérieux Receives Dual 510(k) Clearance And CLIA Waiver From The FDA For The BIOFIRE SPOTFIRE Vaginitis Panel | CI |
| Market Cap | 10.61B 11.85B 9.79B 8.86B 16.56B 1,128B 16.83B 117B 46.59B 590B 44.45B 43.51B 1,870B | P/E 2026 * |
22x | P/E 2027 * | 20x |
|---|---|---|---|---|---|
| Enterprise Value | 10.2B 11.39B 9.41B 8.51B 15.92B 1,084B 16.18B 112B 44.78B 567B 42.73B 41.82B 1,797B | EV / Sales 2026 * |
2.47x | EV / Sales 2027 * | 2.26x |
| Free-Float |
33.22% | Yield 2026 * |
1.17% | Yield 2027 * | 1.29% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BIM | Real-time | |
CBOE
| BIMp | Real-time | |
|
London S.E.
| 0RUG | Delayed | |
|
Boerse Muenchen
| EYWN | Real-time | |
|
Börse Stuttgart
| EYWN | Delayed | |
|
OTC Markets
| BMXMF | Delayed | |
|
Tradegate
| EYWN | Real-time | |
|
Deutsche Boerse AG
| EYWN | Delayed | |
|
CBOE
| 0RUG | Real-time | |
|
Wiener Boerse
| BIM | End-of-day quote |
Last Transcript: bioMérieux
| 1 day | -0.93% | ||
| 1 week | +4.52% | ||
| Current month | +15.95% | ||
| 1 month | +13.11% | ||
| 3 months | +20.28% | ||
| 6 months | +29.15% | ||
| Current year | -18.27% |
| 1 week | 87.7 |  | 92.4 |
| 1 month | 75.35 | | 92.4 |
| Current year | 65.6 | | 116.1 |
| 1 year | 65.6 | | 116.1 |
| 3 years | 65.6 | | 128.3 |
| 5 years | 65.6 | | 133.2 |
| 10 years | 42.68 | | 144.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 53 | 2023-06-30 |
| Director of Finance/CFO | 50 | 2018-02-28 | |
| Chief Tech/Sci/R&D Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 51 | 2017-12-14 | |
| Director/Board Member | 66 | 2004-12-31 | |
| Director/Board Member | 61 | 2012-05-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/31/26 | Free | Chief Executive Officer | 9,200 | 0.0078% | ||
| 8/31/26 | Free | Chief Technology Officer | 1,203 | 0.0010% | ||
| 8/31/26 | Free | Chief Financial Officer | 737 | 0.0006% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.93% | +4.52% | -20.50% | +1.84% | 11.94B | |
| +1.88% | +2.01% | -15.96% | +12.62% | 178B | |
| +2.55% | +1.52% | -15.65% | +19.03% | 117B | |
| +2.46% | +0.54% | +5.87% | +39.87% | 116B | |
| +0.28% | +2.53% | -43.87% | +6.06% | 91.03B | |
| +1.91% | -2.35% | -0.79% | +76.15% | 61.89B | |
| +0.17% | 0.00% | +10.58% | +84.15% | 55.85B | |
| +1.63% | -1.04% | +9.27% | -21.17% | 53.16B | |
| +2.32% | +1.63% | -8.23% | +47.17% | 44.35B | |
| +1.94% | +5.08% | -1.18% | -6.94% | 33.59B | |
| Average | +1.18% | +1.40% | -8.05% | +25.88% | 76.2B | |
| Weighted average by Cap. | +1.36% | +1.32% | -9.96% | +25.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.13B 4.62B 3.81B 3.45B 6.45B 440B 6.56B 45.51B 18.15B 230B 17.32B 16.95B 729B | 4.36B 4.87B 4.02B 3.64B 6.8B 463B 6.91B 47.98B 19.14B 243B 18.26B 17.87B 768B |
| Net income | 486M 542M 448M 406M 758M 51.65B 771M 5.35B 2.13B 27.03B 2.04B 1.99B 85.62B | 532M 594M 491M 444M 831M 56.58B 844M 5.86B 2.34B 29.61B 2.23B 2.18B 93.78B |
| Net Debt | -412M -460M -380M -344M -643M -43.82B -654M -4.54B -1.81B -22.93B -1.73B -1.69B -72.64B | -742M -828M -684M -619M -1.16B -78.86B -1.18B -8.16B -3.26B -41.27B -3.11B -3.04B -131B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-29 | €90.15 | -0.93% | 178,761 |
| 26-10-28 | €91.00 | +1.62% | 177,581 |
| 26-10-27 | €89.55 | +0.79% | 98,057 |
| 26-10-26 | €88.85 | -0.39% | 104,329 |
| 26-10-23 | €89.20 | +1.08% | 166,304 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIM Stock
Select your edition
All financial news and data tailored to specific country editions
